Edition:
United States

Guizhou Yibai Pharmaceutical Co Ltd (600594.SS)

600594.SS on Shanghai Stock Exchange

8.75CNY
14 Feb 2018
Change (% chg)

¥0.07 (+0.81%)
Prev Close
¥8.68
Open
¥8.58
Day's High
¥8.82
Day's Low
¥8.58
Volume
6,088,156
Avg. Vol
11,273,930
52-wk High
¥20.30
52-wk Low
¥8.36

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.11 December 19 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 2 2 3
(2) OUTPERFORM 1 1 2 4
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 1.75 1.80 1.75

Consensus Estimates Analysis

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 1 899.09 899.09 899.09 1,119.92
Quarter Ending Jun-18 1 1,198.79 1,198.79 1,198.79 1,493.22
Year Ending Dec-18 3 4,724.48 4,887.00 4,495.44 5,113.63
Earnings (per share)
Quarter Ending Mar-18 1 0.11 0.11 0.11 0.16
Quarter Ending Jun-18 1 0.15 0.15 0.15 0.21
Year Ending Dec-18 3 0.66 0.77 0.55 0.82

Historical Surprises

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1,209.22 922.62 286.60 23.70
Quarter Ending Jun-17 1,121.89 1,020.94 100.95 9.00
Quarter Ending Mar-17 943.57 930.95 12.62 1.34
Quarter Ending Dec-16 1,368.77 1,002.15 366.62 26.78
Quarter Ending Sep-16 1,105.59 958.63 146.96 13.29

Consensus Estimates Trend

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 899.09 899.09 1,061.11 1,061.11 1,119.92
Quarter Ending Jun-18 1,198.79 1,198.79 1,414.81 1,414.81 1,493.22
Year Ending Dec-18 4,724.48 4,724.48 4,994.51 4,999.63 5,113.63

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 1
Quarter Ending Jun-18 0 0 0 1
Year Ending Dec-18 0 0 0 1
Earnings